Seroatlas · Human Serome Atlas

CLDN34

Claudin-34

Also known as: CLD34_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
H7C241
Gene
CLDN34
Ensembl
ENSG00000234469
Chromosome
X
Canonical length
214 aa
Protein class
Predicted membrane proteins

OverviewNCBI Gene

Predicted to enable structural molecule activity. Predicted to be involved in bicellular tight junction assembly and cell adhesion. Predicted to be active in bicellular tight junction and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]

Canonical amino-acid sequenceUniProt

214 residues, UniProt reviewed canonical sequence.

>H7C241|CLDN34
     1  MVWFCNSADC QFSVFALTTI GWILSSTSTG LVEWRIWYMK DTSLYPPGIA CVGIFRVCIY
    61  RRRTNSTTTK FCYRYSYQDT FLPFEISMAQ RFLLTASIFG FFGRAFNMFA LRNMSMRMFE
   121  EDTYNSFVVS GILNIAAGVF NLIAVLQNYD AVINSQGITF LPSLQMPFKP DVQEVGTAIQ
   181  VAGIGVLPML LTGMFSLFYK CPPYGQVHPG ISEM

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CLDN34 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
4
Mean surface accessibility (rSASA)
0.31
Highest tissue expression
1.6 nTPM

Expression across tissuesHPA

Tissue

  • testis: 1.6 nTPM
  • retina: 0.5 nTPM
  • skin: 0.2 nTPM
  • epididymis: 0.1 nTPM
  • esophagus: 0.1 nTPM
  • liver: 0.1 nTPM

Single-cell type

  • early spermatids: 11 nCPM
  • late primary spermatocytes: 10 nCPM
  • late spermatids: 8.3 nCPM
  • retinal ganglion cells: 3.9 nCPM
  • conjunctival goblet cells: 1 nCPM
  • prostatic hillock cells: 1 nCPM

Immune cell

  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM
  • intermediate monocyte: 0 nTPM
  • MAIT T-cell: 0 nTPM

Brain region

  • cerebral cortex: 1.8 nTPM
  • hippocampal formation: 1.1 nTPM
  • white matter: 1 nTPM
  • basal ganglia: 0.9 nTPM
  • choroid plexus: 0.9 nTPM
  • hypothalamus: 0.9 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about CLDN34.

Disease | ImmuneIEDB

Conditions an epitope on CLDN34 was assayed in.

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CLDN34 as an antibody target. Whether an autoantibody or antibody against CLDN34 could matter depends on whether native CLDN34 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CLDN34 is annotated at the cell surface, where native CLDN34 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label CLDN34 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CLDN34. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...